Exploring the Stages of CKD

Expert discusses how chronic kidney disease (CKD) progresses through defined stages determined by estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR) levels, each representing a measurable decline in kidney function. Early stages are often asymptomatic, but each progression heightens cardiovascular risk. Understanding these thresholds enables clinicians to identify and intervene before irreversible damage occurs.

Expert discusses how awareness of CKD staging remains insufficient among both providers and patients. Many individuals are unaware of their risk level, which delays treatment and lifestyle changes. Improving health literacy about these stages empowers patients to engage in preventive care and promotes clinician adherence to monitoring protocols.

Expert discusses how consistent staging awareness also supports population health management. By categorizing patients accurately, health care systems can tailor interventions, allocate resources efficiently and reduce complications, improving both outcomes and cost-effectiveness.